<DOC>
	<DOCNO>NCT00354094</DOCNO>
	<brief_summary>The purpose study assess long term ( 2 year ) safety tolerability [ S , S ] -Reboxetine patient pain shingle .</brief_summary>
	<brief_title>S , S-Reboxetine Long Term Safety Study In Post-Shingles Pain .</brief_title>
	<detailed_description />
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Patients must pain present 3 month heal shingle skin rash . Patients screen must score &gt; /=40mm pain visual analogue scale . Patients significant hepatic impairment . Patients severe pain , may impair selfassessment pain due postherpetic neuralgia ( pain shingle ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>